Axogen (AXGN) Current Leases (2019 - 2026)
Axogen's (AXGN) quarterly Current Leases came in at $2.1 million in Q1 2026, up 1.34% year-on-year from $2.1 million in Q1 2025, and down 10.83% quarter-over-quarter from $2.4 million in Q4 2025.
Axogen (AXGN) Current Leases (2019 - 2026) Analysis & Trends
Axogen's Current Leases history runs 8 years deep, the most recent figure standing at $2.1 million for Q1 2026.
- On a quarterly basis, Current Leases rose 1.34% year-over-year to $2.1 million in Q1 2026; TTM through Mar 2026 was $2.1 million, a 1.34% increase from a year earlier, with the FY2025 full-year figure at $2.4 million, up 20.47% from the prior year.
- Current Leases retreated to $2.1 million in Q1 2026 per AXGN's latest filing, from $2.4 million in the prior quarter.
- Across five years, Current Leases topped out at $2.4 million in Q4 2025 and bottomed at $1.0 million in Q2 2023.
- The 5-year median for Current Leases is $1.8 million (2022), against an average of $1.7 million.
- Across the five-year window, Current Leases plunged 49.35% in 2023 and jumped 69.34% in 2024, its largest moves.
- Year by year, Current Leases stood at $1.3 million in 2022, then rose by 18.09% to $1.5 million in 2023, then climbed by 27.28% to $2.0 million in 2024, then grew by 20.47% to $2.4 million in 2025, then decreased by 10.83% to $2.1 million in 2026.
- Per Business Quant, the three latest AXGN Current Leases figures stand at $2.1 million (Q1 2026), $2.4 million (Q4 2025), and $2.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 24.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 20.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Axogen | 2.05 Bn | 1.95 Bn | 46.19 Mn | 2.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.12 Mn |
| Dec 31, 2025 | 2.37 Mn |
| Sep 30, 2025 | 2.34 Mn |
| Jun 30, 2025 | 2.21 Mn |
| Mar 31, 2025 | 2.09 Mn |
| Dec 31, 2024 | 1.97 Mn |
| Sep 30, 2024 | 1.86 Mn |
| Jun 30, 2024 | 1.75 Mn |
| Mar 31, 2024 | 1.64 Mn |
| Dec 31, 2023 | 1.55 Mn |
| Sep 30, 2023 | 1.10 Mn |
| Jun 30, 2023 | 1.04 Mn |
| Mar 31, 2023 | 1.05 Mn |
| Dec 31, 2022 | 1.31 Mn |
| Sep 30, 2022 | 1.53 Mn |
| Jun 30, 2022 | 1.76 Mn |
| Mar 31, 2022 | 2.07 Mn |
| Dec 31, 2021 | 1.83 Mn |
| Sep 30, 2021 | 1.67 Mn |
| Jun 30, 2021 | 1.79 Mn |